COLLEONI, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 363
AS - Asia 125
NA - Nord America 75
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 581
Nazione #
IT - Italia 342
US - Stati Uniti d'America 71
BD - Bangladesh 50
SG - Singapore 34
CN - Cina 15
FI - Finlandia 13
VN - Vietnam 10
BR - Brasile 5
FR - Francia 4
HK - Hong Kong 4
ES - Italia 3
IN - India 3
JP - Giappone 3
AR - Argentina 2
CA - Canada 2
CL - Cile 2
EC - Ecuador 2
CG - Congo 1
DE - Germania 1
DZ - Algeria 1
ID - Indonesia 1
IQ - Iraq 1
JM - Giamaica 1
MA - Marocco 1
MX - Messico 1
NP - Nepal 1
PH - Filippine 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 577
Città #
Genoa 215
Vado Ligure 81
Rapallo 23
San Jose 19
Singapore 19
Helsinki 12
Council Bluffs 6
New York 5
Ashburn 4
Buffalo 4
Hanoi 4
Hong Kong 4
Beijing 3
Delhi 3
Espartinas 3
Los Angeles 3
Santa Clara 3
Tokyo 3
Avon 2
Chicago 2
Genova 2
Ho Chi Minh City 2
Lauterbourg 2
Baghdad 1
Baton Rouge 1
Bekasi 1
Boca Toma 1
Bologna 1
Bordighera 1
Brazzaville 1
Bình Phước 1
Cachoeiro de Itapemirim 1
Cadoneghe 1
Cagliari 1
Calamba 1
Campos dos Goytacazes 1
Cariacica 1
Castellaneta 1
Charlotte 1
Concord 1
Decatur 1
Denver 1
Falkenstein 1
Florence 1
Fremont 1
Gallarate 1
Gragnano 1
Guangzhou 1
Guayaquil 1
Hartford 1
Houston 1
Jarinu 1
Jhāpā Bajār 1
Khenchela 1
Lago Puelo 1
Lappeenranta 1
Le Mesnil-en-Vallée 1
Lấp Vò 1
Machala 1
McMinnville 1
Melipilla 1
Mexico City 1
Milan 1
Norristown 1
Owings Mills 1
Paris 1
Parma 1
Pasadena 1
Pattaya 1
Providence 1
Reggio Emilia 1
Rome 1
Santiago 1
Sassuolo 1
Seregno 1
Tangier 1
Tashkent 1
Toronto 1
Verona 1
Victoriaville 1
Windham Center 1
Xaxim 1
Totale 483
Nome #
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer 182
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study 162
Serum thymidine kinase activity in patients with hormone receptor-positive and HER2-negative metastatic breast cancer treated with palbociclib and fulvestrant 90
Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer 75
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: The EORTC 1307-BCG/ BIG5–13/TESARO PR-30–50–10-C BRAVO Study 72
Totale 581
Categoria #
all - tutte 1.919
article - articoli 1.919
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 0 0 0 0 0 2 0 0 1
2022/202326 1 0 0 0 3 1 0 8 4 0 8 1
2023/202433 1 5 0 5 2 3 2 7 0 1 1 6
2024/2025178 4 5 6 15 32 30 19 22 4 7 21 13
2025/2026329 41 5 21 23 31 13 40 7 19 25 64 40
2026/202712 12 0 0 0 0 0 0 0 0 0 0 0
Totale 581